Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
UCM Technologies is a biotechnology company specializing in the development of advanced regenerative medicine solutions through its proprietary Universal Cell Matrix (UCM) platform. The company focuses on creating bioactive scaffolds that mimic the natural extracellular matrix to facilitate tissue repair and regeneration across various clinical applications. Their product portfolio primarily targets wound care, orthopedics, and soft tissue reconstruction, providing clinicians with tools to enhance healing in complex surgical and chronic wound environments. By leveraging stem cell-compatible materials, UCM Technologies aims to bridge the gap between traditional medical devices and advanced cellular therapies. The company is currently commercializing its lead products while expanding its research into specialized regenerative applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on UCM Technologies.